C-Peptide Does Not Affect Ocular Blood Flow in Patients With Type 1 Diabetes
Open Access
- 1 September 2006
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 29 (9), 2034-2038
- https://doi.org/10.2337/dc06-0134
Abstract
OBJECTIVE—The aim of the present study was to investigate the effect of intravenous C-peptide infusion on ocular blood flow in patients with type 1 diabetes under euglycemic conditions.Keywords
This publication has 23 references indexed in Scilit:
- Impaired Endothelial Function of the Retinal Vasculature in Hypertensive PatientsStroke, 2004
- Residual C-peptide secretion and endothelial function in patients with Type II diabetesClinical Science, 2003
- Effects of C‐peptide on forearm blood flow and brachial artery dilatation in patients with type 1 diabetes mellitusActa Physiologica Scandinavica, 2001
- Evaluation of the Zeiss retinal vessel analyserBritish Journal of Ophthalmology, 2000
- C-peptide potentiates the vasoconstrictor effect of neuropeptide Y in insulin-dependent diabetic patientsActa Physiologica Scandinavica, 1999
- Effect of angiotensin-converting enzyme inhibition with perindopril and β-blockade with atenolol on retinal blood flow in hypertensive diabetic subjectsMetabolism, 1998
- Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus.JCI Insight, 1998
- Nitric oxide and ocular blood flow in patients with IDDMDiabetes, 1997
- Topical measurement of fundus pulsationsOptical Engineering, 1995
- Arterial, arterialized venous, venous and capillary blood glucose measurements in normal man during hyperinsulinaemic euglycaemia and hypoglycaemiaDiabetologia, 1992